- Nu-3 is a Bisphosphocin-class antimicrobial.
- Data presented at IDWeek 2026 on October 22, 2026.
Lakewood-Amedex (LABT) presented data at IDWeek 2026 showing Nu-3's rapid bactericidal activity against resistant pathogens and low resistance potential. Phase 2a topline data for infected diabetic foot ulcers expected Q1 2027.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.